Evidence map›Paper›PMID 38164229›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2024

Comparison between

Aynur Ozen, Tarik Sayin, Ozan Kandemir, Ozgul Ekmekcioglu, Serdar Altınay, Eylem Bastug, Ali Muhammedoglu, Atilla Celik, Ramazan Albayrak

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Aynur OzenDepartment of Nuclear Medicine, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Tarik SayinDepartment of Radiology, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Ozan KandemirDepartment of Nuclear Medicine, Mugla Training and Research Hospital, Mugla Sıtkı Kocman University, Mugla, Turkey.
Ozgul EkmekciogluDepartment of Nuclear Medicine, Istanbul Sisli Hamidiye Etfal Training and Research Hospital, University of HealthSciences, Istanbul, Turkey.
Serdar AltınayDepartment of Pathology, Istanbul Bakırköy Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Eylem BastugDepartment of Nuclear Medicine, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Ali MuhammedogluDepartment of Pathology, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Atilla CelikDepartment of General Surgery, Istanbul Bagcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Ramazan AlbayrakDepartment of Radiology, Istanbul Medeniyet University, Faculty of Medicine, Istanbul, Turkey.
Istanbul Medeniyet University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Breast carcinoma is the most common type of cancer in females. This study aims to compare fluorine-18-fluorodeoxyglucose ( Methods: This study included 40 breast carcinoma lesions taken from 39 patients. After staging by positron emission tomography-computed tomography (PET/CT) and diffusion-weighted magnetic resonance imaging (MRI), breast surgery with axillary lymph node dissection or sentinel lymph node biopsy was performed. Results: Primary lesion detection rate for PET/CT and diffusion-weighted MRI was high with 39 of 40 lesions (97.5%). The sensitivity and specificity for the detection of metastatic lymph nodes in axilla were 40.9%, 88.9%, with Conclusions: This study confirmed the high detection rate of breast carcinoma in both modalities. They have same sensitivity for the detection of axillary lymph node metastases, whereas the PET/CT scan had higher specificity. Furthermore, ADC, SUV

Indexed as

Apparent diffusion coefficient Diffusion magnetic resonance imagingBreast carcinomaPositron emission tomographyStandardized maximal uptake

Identifiers

PMID38164229
PMCPMC10757063
OpenAlexW4390508176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.